The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125761952 12576195 2 F 2016 20160726 20160720 20160808 EXP CA-ALEXION PHARMACEUTICALS INC.-A201605264 ALEXION 0.00 M Y 0.00000 20160808 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125761952 12576195 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW A74527BP01 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
125761952 12576195 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W A74527BP01 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
125761952 12576195 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W AE7317B04 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
125761952 12576195 4 C PREDNISONE. PREDNISONE 1 Oral 5-20 MG QD 0 QD
125761952 12576195 5 C FOLIC ACID. FOLIC ACID 1 Unknown 5 MG, QD 0 5 MG QD
125761952 12576195 6 C NOVORAPID INSULIN ASPART 1 Subcutaneous UNK, PRN AS PER GLYCEMIA 0 /yr
125761952 12576195 7 C LISINOPRIL. LISINOPRIL 1 Oral 5 MG, QD 0 5 MG QD
125761952 12576195 8 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, BID 0 1000 MG BID
125761952 12576195 9 C FLOMAX TAMSULOSIN HYDROCHLORIDE 1 Oral 0.4 MG, QD 0 .4 MG QD
125761952 12576195 10 C DIDROCAL CALCIUM CARBONATEETIDRONATE DISODIUM 1 Oral 1 TABLET, QD 0 TABLET QD
125761952 12576195 11 C LEVEMIR INSULIN DETEMIR 1 Subcutaneous 12 UNITS, QHS 0 QD
125761952 12576195 12 C TYLENOL ACETAMINOPHEN 1 Oral 500-1000 MG, PRN 0 /yr
125761952 12576195 13 C COUMADIN WARFARIN SODIUM 1 Oral 5 MG, QD 0 5 MG QD
125761952 12576195 14 C MELATONIN MELATONIN 1 Oral 1 TABLET, QHS 0 TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125761952 12576195 1 Paroxysmal nocturnal haemoglobinuria
125761952 12576195 4 Product used for unknown indication
125761952 12576195 5 Product used for unknown indication
125761952 12576195 6 Diabetes mellitus
125761952 12576195 7 Cardiac failure congestive
125761952 12576195 8 Diabetes mellitus
125761952 12576195 9 Product used for unknown indication
125761952 12576195 10 Product used for unknown indication
125761952 12576195 11 Diabetes mellitus
125761952 12576195 12 Pain
125761952 12576195 13 Anticoagulant therapy
125761952 12576195 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125761952 12576195 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125761952 12576195 Contusion
125761952 12576195 Cough
125761952 12576195 Lower respiratory tract infection
125761952 12576195 Nasopharyngitis
125761952 12576195 Obstructive airways disorder
125761952 12576195 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125761952 12576195 1 20120503 20120524 0
125761952 12576195 2 20120531 0
125761952 12576195 3 20120531 0